Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06482073 · ClinicalTrials.gov registry record
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
A clinical trial of Lung Carcinoma and Metastatic Malignant Neoplasm in the Lung, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06482073 is a study of Lung Carcinoma and Metastatic Malignant Neoplasm in the Lung that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 5,043-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06482073, a study of Lung Carcinoma and Metastatic Malignant Neoplasm in the Lung, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-24 |
| Est. Completion | 2027-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06482073
The ClinicalTrials.gov registry entry for NCT06482073 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,043-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06482073 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06482073 about?
NCT06482073 is a clinical study titled "Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)". This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.
What is the current status of trial NCT06482073?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-06-24. Estimated completion is 2027-07-01.
What conditions does trial NCT06482073 study?
This clinical trial studies the following conditions: Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung.
What interventions are being tested in trial NCT06482073?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06482073?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06482073 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
The Rise in Robotic Atypical Segmentectomies
RECRUITING
-
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.